Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product: Somatuline LA
Active Ingredient: Lanreotide 30mg
Dosage Form: Powder for injection
Diluent
New Zealand Sponsor: New Zealand Medical & Scientific Limited
Manufacturer: Pharma Biotech, de Signes, Chemin, France
Dated this 7th day of September 2007.
ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).